SEC Tracker
Get the app

Marpai MRAI

Marpai reports $13.55 million net loss for 2025.

Proxy statement

Form
DEF 14A
Filed
Importance
Routine
  1. Net loss of $13.55 million for the year ended Dec 31, 2025.
  2. Annual meeting scheduled for Dec 9, 2026.
  3. Ratify UHY LLP as independent auditors for 2026.

Written from the DEF 14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Marpai files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8090 and related industry codes: the same peer list as the financial tables.

  1. BioRestorative Therapies BRTX public float $11M, Jun 30, 2025
  2. Mangoceuticals MGRX public float $15M, Jun 30, 2025
  3. Elite Health Systems EHSI public float $24M, Jun 30, 2025
  4. Cryo Cell International CCEL public float $27M, May 31, 2025
  5. Pacific Health Care Organization PFHO public float $3M, Jun 30, 2025